Skip to main content

and
  1. Article

    Open Access

    Specific detection of tau seeding activity in Alzheimer’s disease using rationally designed biosensor cells

    The prion-like propagation of tau in neurodegenerative disorders implies that misfolded pathological tau can recruit the normal protein and template its aggregation. Here, we report the methods for the develop...

    Aurelien Lathuiliere, Youhwa Jo, Romain Perbet in Molecular Neurodegeneration (2023)

  2. Article

    Open Access

    Tau seeding and spreading in vivo is supported by both AD-derived fibrillar and oligomeric tau

    Insoluble fibrillar tau, the primary constituent of neurofibrillary tangles, has traditionally been thought to be the biologically active, toxic form of tau mediating neurodegeneration in Alzheimer’s disease. ...

    Anastasie Mate De Gerando, Lindsay A. Welikovitch, Anita Khasnavis in Acta Neuropathologica (2023)

  3. Article

    Author Correction: Tau molecular diversity contributes to clinical heterogeneity in Alzheimer’s disease

    A Correction to this paper has been published: https://doi.org/10.1038/s41591-021-01251-7.

    Simon Dujardin, Caitlin Commins, Aurelien Lathuiliere, Pieter Beerepoot in Nature Medicine (2021)

  4. Article

    Open Access

    Synaptic and metabolic gene expression alterations in neurons that are recipients of proteopathic tau seeds

    Recent studies suggest that misfolded tau molecules can be released, and taken up by adjacent neurons, propagating proteopathic seeds across neural systems. Yet critical to understanding whether tau propagatio...

    Marta Perez-Rando, Simon Dujardin in Acta Neuropathologica Communications (2020)

  5. No Access

    Article

    Tau molecular diversity contributes to clinical heterogeneity in Alzheimer’s disease

    Alzheimer’s disease (AD) causes unrelenting, progressive cognitive impairments, but its course is heterogeneous, with a broad range of rates of cognitive decline1. The spread of tau aggregates (neurofibrillary ta...

    Simon Dujardin, Caitlin Commins, Aurelien Lathuiliere, Pieter Beerepoot in Nature Medicine (2020)

  6. No Access

    Article

    Tau impairs neural circuits, dominating amyloid-β effects, in Alzheimer models in vivo

    The coexistence of amyloid-β (Aβ) plaques and tau neurofibrillary tangles in the neocortex is linked to neural system failure and cognitive decline in Alzheimer’s disease. However, the underlying neuronal mech...

    Marc Aurel Busche, Susanne Wegmann, Simon Dujardin, Caitlin Commins in Nature Neuroscience (2019)

  7. Article

    Open Access

    An acute functional screen identifies an effective antibody targeting amyloid-β oligomers based on calcium imaging

    Soluble amyloid β oligomers (AβOs) are widely recognized neurotoxins that trigger aberrant signaling in specific subsets of neurons, leading to accumulated neuronal damage and memory disorders in Alzheimer’s d...

    Xueying Wang, Ksenia V. Kastanenka, Michal Arbel-Ornath in Scientific Reports (2018)

  8. Article

    Open Access

    Neuronal uptake and propagation of a rare phosphorylated high-molecular-weight tau derived from Alzheimer’s disease brain

    Tau pathology is known to spread in a hierarchical pattern in Alzheimer’s disease (AD) brain during disease progression, likely by trans-synaptic tau transfer between neurons. However, the tau species involved...

    Shuko Takeda, Susanne Wegmann, Hansang Cho, Sarah L. DeVos in Nature Communications (2015)